Profiles

Executive Vice President, Research & Development

“I came to science because I was curious – I loved asking questions and finding answers in the data. It’s not always smooth, but the challenges are worth it when you know the goal is helping people. We’re all patients at some point. Using science to make a difference, whether today or tomorrow, is a privilege that motivates me every day.”​

Christelle joined Ipsen in 2020 with extensive experience indrug discovery and development across multiple therapeutic areas, having held senior scientific roles at X-Chem, Alexion, and Pfizer. She holds a Ph.D. in Molecularand Cellular Biology from the Pasteur Institute. At Ipsen, Chriselle leads R&D from discovery through late-stage development across Oncology, Rare Disease, and Neuroscience, and is also accountable for the company’s External Innovation strategy. Since joining, she has transformed and expanded the portfolio to build strong franchises including Ipsen’s leading work in rare liver diseases, and expanding Ipsen’s early development pipeline into new areas – featuring best and first-in class assets in pioneering modalities such as Antibody Drug Conjugates and T Cell Engagers. Key achievements include advancing multiple assets into Phase I and beyond and accelerating innovation by successfully guiding key data readouts and driving 7 major regulatory approvals.